Alabama Court Bucks Trend, Says Generic Patient Can Sue Pfizer

, The Litigation Daily

   | 0 Comments

The tort theory of "innovator liability"—the notion that brand-name drug companies can be held liable for inadequate warnings on other manufacturers' generic versions of their drugs—has been widely panned on appeal. But innovator liability isn't dead yet.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202667213697

Thank you!

This article's comments will be reviewed.